SCHEMBL8308824

SCHEMBL8308824

COC(C)(C(=O)O)c1ccccc1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EDNRB P24530 1/20 0.45
▸ EDNRA P25101 1/20 0.45
▸ KCNN4 O15554 6/20 0.45
▸ KCNE1 P15382 1/20 0.41
▸ KCNQ1 P51787 1/20 0.41
▸ AKR1C3 P42330 1/20 0.38
▸ AKR1C2 P52895 1/20 0.38
▸ HDAC6 Q9UBN7 2/20 0.38
▸ HDAC3 O15379 1/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ CES1 P23141 2/20 0.36
▸ POLB P06746 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ KIF11 P52732 1/20 0.35
▸ CES2 O00748 1/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28352146 0.80 TSHR (0.50) KCNN4ALDH1A1CES1MAPTKIF11
SCHEMBL6446346 0.80 GABRA1 (0.37) EDNRBEDNRAKCNN4KCNE1KCNQ1
SCHEMBL19283984 0.79 ALDH1A1 (0.42) KCNN4HDAC6HDAC3HDAC1HDAC2
SCHEMBL30501782 0.77 KCNN4 (0.50) KCNN4KCNE1KCNQ1AKR1C3AKR1C2
SCHEMBL1239901 0.77 KCNN4 (0.50) KCNN4KCNE1KCNQ1AKR1C3AKR1C2
SCHEMBL2723142 0.76 ALDH1A1 (0.51) ALDH1A1GAAKIF11CYP2C19
SCHEMBL29697583 0.76 ALDH1A1 (0.51) ALDH1A1GAAKIF11CYP2C19
SCHEMBL6120771 0.76 ALDH1A1 (0.51) ALDH1A1GAAKIF11CYP2C19
SCHEMBL12940368 0.76 ALDH1A1 (0.51) ALDH1A1GAAKIF11CYP2C19
SCHEMBL29649169 0.76 ALDH1A1 (0.51) ALDH1A1GAAKIF11CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0906310-A4 OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE -g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY MERCK & CO INC (US) 1999-09-01 — — EP disclosed
EP-0906310-A1 OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY Merck & Co., Inc. (US) 1999-04-07 — — EP disclosed
WO-1997046556-A1 OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY MERCK & CO., INC. (US) 1997-12-11 — — WO disclosed
Send feedback